Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.

Source:http://linkedlifedata.com/resource/pubmed/id/17550426

Download in:

View as

General Info

PMID
17550426